Search clinical trials for: EMPA/LINA 10/5 mg QD (n=22)
Total 16 results
-
M.H.H. KramerActive, not recruitingType2 DiabetesNetherlands
-
NeuroActiva, Inc.CompletedNeurocognitive Disorders | Neurodegenerative Diseases | Cognitive Impairment | Alzheimer Disease | Tauopathies | Mild Cognitive Impairment | Dementia, Vascular | Dementia With Lewy Bodies | Alzheimer Dementia | Cognitive DisorderNew Zealand
-
PfizerCompletedDiabetes Mellitus, Type 2United States, Colombia, Spain, Germany, Sweden, Italy
-
Nordic Pharma, USANutrasource Pharmaceutical and Nutraceutical Services, Inc.CompletedComparative BioavailabilityCanada
-
Amsterdam UMC, location VUmcCompletedType 2 DiabetesNetherlands
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
ErydelCompletedGenetic Syndrome | Nervous System DiseaseIndia, United States, Israel, Australia, Belgium, Germany, Italy, Norway, Poland, Spain, Tunisia, United Kingdom
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompletedDiabetes Mellitus, Type 2China
-
Karolinska InstitutetCompleted
-
Zambon SpAEnrolling by invitationBronchiolitis Obliterans | Bronchiolitis Obliterans Syndrome | Obliterative BronchiolitisFrance, United States, Spain, Israel, Belgium, Denmark, Germany, United Kingdom, Austria
-
Jonsson Comprehensive Cancer CenterMirati Therapeutics Inc.; Phase One FoundationRecruitingRhabdomyosarcomaUnited States
-
EMSWithdrawnType2 Diabetes Mellitus
-
University Hospital, Basel, SwitzerlandRecruiting
-
Netherlands Institute for Pigment DisordersAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Completed
-
Stanford UniversityCompletedLymphoma | Hodgkin Disease | Lymphoma, Hodgkin Disease | Lymphoma: HodgkinUnited States
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany